Sort
130,381 grants matching “hiv”
Molecular Detection of Invasive Fungal Infections
$988,975Neil X Krueger · Immunetics, Inc. · R44 · FY2017 · AI
The Effectiveness of Automated Multimodal Imaging in High Grade Squamous Intraepithelial Lesions (HSIL) Diagnosis for People Living with HIV: An International Trial
$988,950Sharmila Anandasabapathy · Baylor College Of Medicine · R01 · FY2024 · CA
Anti-HIV Microbicide: Cellulose Acetate Phthalate (CAP)
$988,856New York Blood Center · P01 · FY2001 · HD
Complete Genome Variation in Africans with Extreme HIV-1 Transmission Phenotypes
$988,775Jairam Rao Lingappa · University Of Washington · R01 · FY2011 · AI
Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM)
$988,753C. Hendricks Brown · Northwestern University At Chicago · P30 · FY2016 · DA
AN OBSERVATIONAL STUDY OF TREATED AND UNTREATED ACUTE AND EARLY HIV-1 INFECTION
$988,655Rockefeller University · M01 · FY2005 · RR
Antibody Effector Function in Protection Against HIV-1
$988,622Dennis R. Burton · Scripps Research Institute, The · R37 · FY2016 · AI
Dendritic Cell-Targeted HIV Vaccine Product
$988,487Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2015 · AI
HIV and HCC in Africa: The H2A Consortium
$988,451Gregory D Kirk · Johns Hopkins University · U54 · FY2021 · CA
Fogarty AIDS International Training &Research Program
$988,380Johns Hopkins University · D43 · FY2003 · TW
Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach
$988,320Nwora Lance Okeke · Duke University · R01 · FY2023 · AI
Opiate drug abuse and CNS vulnerability to HIV
$988,298Kurt Francis Hauser · University Of Kentucky · P01 · FY2006 · DA
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$988,293Michelle M. Butler · Microbiotix, Inc · R44 · FY2015 · AI
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
$988,290Kathryn M Anastos · Albert Einstein College Of Medicine · U54 · FY2020 · CA
TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime
$988,286Michael L Dennis · Chestnut Health Systems, Inc. · U01 · FY2019 · DA
Clinical Core
$988,221Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
The Microbial Ecology of Bacterial Vaginosis: A Fine Scale Resolution Metagenomic
$987,891Jacques Ravel · University Of Maryland Baltimore · UH2 · FY2009 · AI
Yeast Engineering Technology & Immunobiology Core
$987,808Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Clinical Trials Network: North Texas Node
$987,791University Of Texas Sw Med Ctr/Dallas · U10 · FY2005 · DA
Structural Biology of HIV Assembly and Maturation
$987,649Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine
$987,515Kevin Trabbic · Bluewillow Biologics, Inc. · R44 · FY2022 · AI
Antibody Neutralization Mechanisms
$987,511Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Modulating mucosal DCs and T cells to limit SIV spread
$987,500Melissa J Robbiani · Population Council · R37 · FY2009 · AI
The HMP Next Gen digital health platform: accelerating research implementation, amplifying public health impact
$987,455Nickie Buckner · One Cow Standing, Llc · R44 · FY2024 · MD
HIV and HCC in Africa: The H2A Consortium
$987,283Gregory D Kirk · Johns Hopkins University · U54 · FY2024 · CA